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Abstract
 
Notch1 signaling is required for T cell development. We have previously demonstrated that
expression of a dominant active Notch1 (ICN1) transgene in hematopoietic stem cells (HSCs)
 
leads to thymic-independent development of CD4
 
 
 
CD8
 
 
 
 double-positive (DP) T cells in the
bone marrow (BM). To understand the function of Notch1 in early stages of T cell develop-
ment, we assessed the ability of ICN1 to induce extrathymic T lineage commitment in BM
progenitors from mice that varied in their capacity to form a functional pre-T cell receptor
 
(TCR). Whereas mice repopulated with ICN1 transduced HSCs from either recombinase
 
deficient (Rag-2
 
 
 
/
 
 
 
) or Src homology 2 domain–containing leukocyte protein of 76 kD
(SLP-76)
 
 
 
/
 
  
 
mice failed to develop DP BM cells, recipients of ICN1-transduced Rag-2
 
 
 
/
 
 
 
progenitors contained two novel BM cell populations indicative of pre-DP T cell develop-
ment. These novel BM populations are characterized by their expression of CD3
 
 
 
 and pre-T
 
 
 
mRNA and the surface proteins CD44 and CD25. In contrast, complementation of Rag-2
 
 
 
/
 
 
 
mice with a TCR
 
 
 
 transgene restored ICN1-induced DP development in the BM within 3
wk after BM transfer (BMT). At later time points, this population selectively and consistently
gave rise to T cell leukemia. These findings demonstrate that Notch signaling directs T lineage
commitment from multipotent progenitor cells; however, both expansion and leukemic trans-
formation of this population are dependent on T cell–specific signals associated with develop-
ment of DP thymocytes.
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Introduction
 
Notch proteins comprise a family of transmembrane re-
ceptors that regulate responsiveness of a wide variety of
cell types to environmental signals (1). Notch1, one of
four family members, binds multiple ligands, including
Delta/Serrate and Jagged (2). After ligand binding, the in-
tracellular region of Notch1 is proteolytically cleaved from
the transmembrane portion and translocated to the nucleus
where it interacts with a transcriptional repressor, known
as CSL (for CBF-1, suppressor of Hairless, and Lag-1) (3).
After binding Notch, CSL becomes a transcriptional acti-
vator, and in conjunction with the activity of other cofac-
tors, including Mastermind, SKIP, PCAF, and/or GCN5,
induces transcription of downstream targets (4–6). Notch
signaling also occurs through a poorly understood CSL-
independent pathway that may involve Deltex (7).
Several studies examining Notch1 expression patterns
and the effect of removing or deregulating Notch1 activity
suggest that Notch1 signaling plays a key role at multiple
steps in T cell development (8). The importance of Notch1
in commitment of early progenitors to the T cell lineage is
underscored by two recent studies. T cells fail to develop in
inducible Notch1 knockout mice (9). Reciprocally, we
have demonstrated that expression of active Notch1 in
 
stem cells induces ectopic CD4
 
 
 
CD8
 
 
 
 development in the
bone marrow (BM) and inhibits early B cell development
(10). Although these studies clearly show that Notch1 is re-
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quired for T cell development, the signaling pathways and
target genes underlying Notch1-mediated T cell commit-
ment are unknown.
Early 
 
 
 
/
 
 
 
 T cell development in the thymus is charac-
terized by lineage commitment followed by V
 
 
 
D
 
 
 
J
 
 
 
 re-
combination and differentiation of precursors expressing a
functional pre-TCR into early CD4
 
 
 
CD8
 
 
 
 thymocytes
(for a review, see reference 11). Lineage commitment and
V
 
 
 
D
 
 
 
J
 
 
 
 recombination occur in discrete cell populations
defined by differential surface expression of CD44 and
CD25. Early thymic progenitors within the CD44
 
 
 
CD25
 
 
 
subset give rise to dendritic cells, NK cells, and T lineage–
committed CD44
 
 
 
CD25
 
 
 
 early pro-T cells. Pre-TCR sig-
naling is requisite for differentiation of late CD44
 
 
 
CD25
 
 
 
pro-T cells into CD4
 
 
 
CD8
 
 
 
 thymocytes as evidenced by
the arrest in T cell development at the CD44
 
 
 
CD25
 
 
 
 stage
after disruption of pre-TCR assembly or signaling (11).
This phenotype is shared by recombination activating gene
(Rag)-1/2
 
 
 
/
 
 
 
 mice and mice lacking the pre-TCR intra-
cellular adapter protein Src homology 2 domain–containing
leukocyte protein of 76 kD (SLP-76) (12–15). Pre-TCR
signaling is also required for the exponential expansion of
thymocyte numbers that occur after successful VDJ re-
combination, as evidenced by decreased thymic cellularity
in Rag- and SLP-76–deficient mice (12–15).
To understand the function of Notch signaling at the
earliest stages of T cell development, we used the ability of
Notch1 to drive thymic-independent T cell development
in the BM of recipients of ICN1-transduced hematopoi-
etic stem cells (HSCs). When ICN1 is introduced into
HSCs of either Rag-2
 
 
 
/
 
 
 
 or SLP-76
 
 
 
/
 
 
 
 mice, double-
positive (DP) cells fail to develop in the BM. However,
ICN1 does promote earlier stages of T cell development
(CD44
 
 
 
CD25
 
 
 
 and CD44
 
 
 
CD25
 
 
 
) in the BM of Rag-
2
 
 
 
/
 
 
 
 mice. These progenitors constitute a small fraction of
total BM cells in these chimeric mice, which remained
healthy for over 1 yr. In contrast, rescue of the Rag-2
 
 
 
/
 
 
 
phenotype with a TCR
 
  
 
transgene allows Notch to drive
DP development in the BM within 3 wk after BM transfer
(BMT). At later time points, these cells give rise to T cell
leukemias. These results show that Notch is required for T
cell commitment but insufficient to rescue the block in
pre-TCR signaling necessary for either T cell expansion or
DP development. Furthermore, signaling by an intact
TCR provides a permissive environment for the develop-
ment of T cell leukemia.
 
Materials and Methods
 
Mice.
 
BALB/c, C57BL/6, Rag-2
 
 
 
/
 
 
 
, and Rag-2
 
 
 
/
 
 
 
 
 
 
 
TCR
 
 
 
 (DO11.10) transgenics were purchased from Taconic. All
experiments were conducted in accordance with National Insti-
tutes of Health guidelines for the care and use of animals and with
an approved animal protocol from the University of Pennsylvania
Animal Care and Use Committee.
 
Retroviral Transduction of BM Precursor Cells.
 
The retroviral
vectors used in these experiments have been described previously
(10, 16). Transduction of BM cells from 5-fluorouracil (5-FU)–
 
treated 4–8-wk-old mice with green fluorescent protein (GFP)-
normalized retroviral supernatants and transplantation of these
cells into lethally irradiated 4–8-wk-old female syngeneic BALB/c
or C57BL/6 mice was performed as described (10, 16). Spinoc-
ulations were performed in medium containing IL-3 (6 ng/ml;
R&D Systems), IL-6 (10 ng/ml; R&D Systems), stem cell factor
(SCF; 100 ng/ml; R&D Systems), and 5% WEHI-conditioned
supernatant as described (10, 16).
 
 
 
On day 3 after BM harvest,
3 
 
 
 
 10
 
5
 
 cells were injected into syngeneic 4–8-wk-old female
mice that had been lethally irradiated (900 rads in a split dose).
Furthermore, identical aliquots of MigR1 and Mig ICN1 retro-
viral supernatants were used to transduce BM progenitors from
Rag-2
 
 
 
/
 
 
 
 and Rag-2
 
 
 
/
 
 
 
 
 
 
 
 TCR
 
 
 
 (DO11.10) mice in two in-
dependent experiments.
 
Flow Cytometry and Cell Sorting.
 
BM cells were prepared and
stained for flow cytometric analysis as described previously (10).
In brief, 10
 
6
 
 BM cells were stained with PE-conjugated anti-
CD8 (Lyt2) and allophycocyanin (APC) anti-CD4 (L3T4) (BD
PharMingen), then analyzed on a dual laser FACSCalibur™
equipped with CELLQuest™ software (Becton Dickinson). Cells
derived from transduced precursors were distinguished from non-
transduced cells by gating on cells with greater than two logs GFP
expression over GFP
 
 
 
 cells. For sorting, BM cells from recipients
of Rag-2
 
 
 
/
 
 
 
 ICN1-transduced HSCs were stained with PE–anti-
CD25 and APC–anti-CD44, then sorted on a Becton Dickinson
FACS Vantage™ equipped with argon 488-nm and HeNe 647-
nm lasers. For cell cycle analysis, cells were permeabilized in
EtOH and then stained with 50 
 
 
 
g/ml propidium iodide and
100 
 
 
 
g/ml RNaseA for 30 min before analysis. All flow cyto-
metric data were analyzed by uploading forward scatter (FSC)
files into FlowJo (Tree Star, Inc.).
 
Reverse Transcription PCR.
 
RNA and cDNA was prepared
and amplified as described (17). In brief, 10
 
5
 
 cells from each pop-
ulation were sorted directly into 400 
 
 
 
l of RNA lysis buffer
consisting of 0.236 M guanidine isothyocyanate, 0.5% sarkosyl,
25 mM Na Citrate, pH 7.0, and 0.7% (vol/vol) 2-ME. After a
phenol/chloroform extraction, RNA was precipitated with iso-
propanol using 1 
 
 
 
g of glycogen as a carrier then resuspended in
20 
 
 
 
l ddH
 
2
 
O. 4 
 
 
 
l of RNA was used for cDNA synthesis in a fi-
nal volume of 20 
 
 
 
l with 1 
 
 
 
l of 1 
 
 
 
g/
 
 
 
l random hexamers, 1
 
 
 
l M-MLV reverse transcriptase (200 U/
 
 
 
l), and 0.5 mM
dNTPs. For amplification, 2–4 
 
 
 
l of cDNA was subjected to a
35 cycle PCR with the following oligonucleotides: CD3
 
 
 
, 5
 
 
 
TGGAACACTTTCTGGGGCATCCTG and 3
 
 
 
 TTTGAG-
GCTGGTGTGTAGCAGACG; pre-T
 
 
 
, 5
 
 
 
 CTCGAGAT-
GCTTCTCCACGAGT and 3
 
 
 
 GTTAACACTATGTCCA-
AATTCT; hypoxanthine phosphoribosyltransferase (HPRT),
5
 
 
 
 CACAGGACTAGAACACCTGC and 3
 
 
 
 GCTGGTGAAA-
AGGACCTCT. For a positive control for pre-T
 
 
 
 expression,
cDNA from the SCID-derived early T cell line SCID.ADH (18)
was provided by Dr. David Wiest (Fox Chase Cancer Center,
Philadelphia, PA). To ensure that analyses were in the linear
range, 10-
 
 
 
l aliquots were withdrawn at 25, 30, and 35 cycles
for separate analysis on 1% agarose gels. HPRT served as a con-
trol to ensure that equal amounts of cDNA were added to each
reaction.
 
Western Blot for Notch1 Expression.
 
Expression of Notch1
polypeptides was determined by Western blot analysis of whole
cell detergent lysates using anti-Notch1 rabbit sera (16). DNA
prepared from diseased and normal tissues by SDS extraction and
proteinase K digestion were analyzed on Southern blots hybrid-
ized to probes for the internal ribosomal entry site (IRES) or mu-
rine TCR
 
 
 
, as described previously (10, 16). 
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Leukemogenesis Assay.
 
Mice were followed after transplanta-
tion by periodic peripheral blood sampling from retroorbital si-
nuses and daily physical inspection. Peripheral blood (PB) was as-
sessed beginning 2 wk after transplant and every 2 wk thereafter
for the presence of GFP
 
 
 
 immature T cells by flow cytometric
analysis using antibodies to CD4 and CD8 (see below). Tissues
were harvested from diseased and unaffected animals after as-
phyxiation with CO
 
2
 
. Mice were monitored for leukemia by
enumerating the white blood cells (WBCs) once every 2 wk and
monitoring the mice daily for signs of cachexia, inactivity, or ill
health. Criteria for the development of leukemia were a WBC
 
 
 
50 
 
 
 
 106 cells/ml and/or the presence of circulating DP T
cells (16).
Results
Notch1-induced Extrathymic T Cells Resemble Normal DP
Thymocytes. To dissect the role of Notch signaling in
early events in T cell development, we exploited the ability
of ICN1 to drive thymic-independent T cell development
in the BM of recipients of ICN1-transduced HSCs (10).
Between 3–4 wk after reconstitution, recipient BM con-
tained T lineage cells that closely resembled normal imma-
ture DP thymocytes (Fig. 1). Both ICN1-induced DP BM
cells and wild-type DP thymocytes expressed similar levels
of TCR, CD3, and CD4/CD8 (Fig. 1, A and B, and data
not shown). Furthermore, both ICN1-induced and wild-
type DP thymocytes were comprised of small resting cells
(Fig. 1, C and D). Our previous results showed that the
ICN1-induced BM T cell population was oligoclonal (10).
These results suggest that the ICN1-induced BM T cell
population provides a physiologically relevant model to
study T cell commitment from multipotential progenitors
as well as the double negative (DN) to DP transition requi-
site for thymocyte development.
Notch1 Signaling Fails to Rescue T Cell Development in Rag-
deficient Cells. Thymocytes from Rag-deficient mice
(Rag-2 / ) do not undergo VDJ recombination, and lack-
ing pre-TCR signaling, fail to differentiate into DP cells
(15). Instead, these thymocytes arrest at the CD44 CD25 
stage of development. The Rag-2 /  induced arrest can be
rescued by activation of lck or the mitogen-activated pro-
tein (MAP) kinase pathway (19–21), suggesting that activa-
tion of appropriate downstream signaling pathways can
compensate for lack of pre-TCR signaling. To evaluate the
ability of activated Notch1 to rescue the Rag-2 /  block in
T cell development, hematopoietic progenitors from Rag-
2 /  BM were transduced with ICN1 and transferred into
lethally irradiated recipients. Whereas mice repopulated
with ICN1-transduced wild-type HSCs generated BM DP
T cells within 3 wk after BMT, mice repopulated with
ICN1 transduced Rag-2 /  HSCs did not, even when fol-
lowed for 1 yr (Fig. 2, and data not shown). Similarly, pro-
genitors from SLP-76 /  mice, which lack an essential
component of the pre-TCR signaling pathway (12, 14),
failed to give rise to ICN1-induced DP T cells in the BM
(Fig. 2). In contrast, the hematopoietic defects in SLP-76 / 
mice were rescued by retroviral transduction of SLP-76 / 
BM cells with SLP-76 (unpublished data). Most BM sam-
ples from recipients also contained both CD4 CD8  and
CD4 CD8  cells. However, these cells were host derived,
as they were evident regardless of donor cell genotype, and
uniformly expressed the host Ly5 allele in separate experi-
ments using Ly5 congeneic donors and recipients (Fig. 2,
and data not shown).
To determine whether BM DP development could be
restored by pre-TCR generated signals, chimeras were
generated after ICN1 transduction of HSCs from Rag-2 / 
mice complemented with the TCR  transgene DO11.10
(22). Within 3 wk after reconstitution with ICN1-express-
ing BM cells, these mice developed DP cells in the BM
(Fig. 2). Together, these results demonstrate that pre-
TCR–derived signals are necessary for the development of
Notch1-induced extrathymic DP T cells.
Notch Signaling Drives T Cell Commitment but Not Expan-
sion in the BM. Although mice repopulated with ICN1-
transduced Rag-2 /  HSCs failed to develop BM DP cells,
Figure 1. Notch1-induced extrathymic T cells
resemble normal DP thymocytes. (A) Flow cyto-
metric analysis for CD4 and CD8 expression on
normal thymocytes versus BM cells from a recipi-
ent of ICN1-transduced wild-type progenitor cells
at 21 d after BMT. Also shown is TCR  expres-
sion (B), forward scatter (C), and DNA content
(D). The TCR  expression (B) and forward scatter
(C) results are based on DP GFP  cells as shown in
panel A. Because GFP is lost after cell permeabiliza-
tion, the analysis in D used ungated BM cells; how-
ever, 95% of the cells in the BM at the time of anal-
ysis were DP GFP . Data are representative of
three recipients.102 Notch1-mediated T Cell Commitment and Malignant Transformation
these mice exhibited unique cell populations in the BM
that parallel earlier stages of thymic T cell development.
ICN1-transduced HSCs from Rag-2 /  mice developed
into both CD44 CD25  and CD44 CD25  populations
in the BM after adoptive transfer (Fig. 3 A). These popula-
tions were restricted to the GFP  fraction of mice given
ICN1-transduced HSCs, as they were absent from mice
given MigR1-transduced HSCs. We showed previously
that GFP expression mirrors ICN1 expression driven by
the Mig ICN1 vector (10, 23), and that the development
of BM CD4 CD8  cells induced by Mig ICN1 is thymus
independent. To confirm that the CD44 CD25  and
CD44 CD25  cells in the ICN1 mice are T lineage pre-
cursors, we isolated each population and performed re-
verse transcription (RT)-PCR for CD3  and pre-T ;
two components of the pre-TCR complex (24). Both
Figure 2. Notch1 induction of
extrathymic DP T cells requires
pre-TCR assembly and signaling.
Progenitor cells from wild-type,
Rag-2 / , Rag-2 /    TCR ,
and SLP-76 mice were trans-
duced with MigR1 control or
MigR1-ICN1 viruses and then
transferred to lethally irradiated
C57BL/6 recipients. BM cells
were stained 20–30 d after trans-
fer with the indicated antibodies
and analyzed by flow cytometry.
GFP gates were set as described
in Materials and Methods. The
CD4  and CD8  SP thymocytes
present in all GFP  populations
are recipient derived, as shown
by prior congenic analysis (data
not shown). Data are representa-
tive of 3–12 recipients for each
donor genotype.
Figure 3. Notch1 signaling induces extrathymic T cell
commitment. Progenitor cells from Rag-2 /  donors were
transduced with MigR1 or MigR1-ICN1 then analyzed
30 d after transfer. (A) Flow cytometric analysis for CD44
and CD25 expression on BM cells from recipients. Data
are representative of six recipients of ICN1-transduced
Rag-2 /  progenitors. (B) RT-PCR analysis for CD3 
and pre-T  mRNA was performed as described in Materi-
als and Methods on sorted populations using the indicated
gates. In the analysis of pre-T  expression cDNA from the
SCID-derived early T cell line SCID.ADH (reference 18)
was included as a positive control (lane marked “ ”), and
from Hardy Fraction D (B220 CD43 IgM  pre-B cells) as
a negative control (lane marked “Fr. D”). Thy III contains
cDNA from purified CD25 CD44 CD3  thymocytes.103 Allman et al. Brief Definitive Report
CD44 CD25  and CD44 CD25  populations express
transcripts for CD3  and pre-T , whereas other BM popu-
lations, which are common to cells derived from both
MigR1 and ICN1 transduced HSCs, do not (Fig. 3 B).
Together, these data support a model in which Notch1 ac-
tivity is sufficient to induce commitment to the T cell lin-
eage, instructing early multipotent progenitors in the BM
to differentiate into T lineage precursor populations.
In wild-type mice, pre-TCR signaling results in expo-
nential expansion of the T cell precursor pool. This is
mimicked in our murine model as the ICN1-induced BM
DP population in both wild-type mice and Rag-2 /   
TCR  mice rapidly expanded to become the dominant
cell population in the BM and spleen (10). In contrast, the
ICN1-induced CD44 CD25  and CD44 CD25  BM
populations constituted 1–4% of all BM cells, and were not
detected in other organs (Fig. 4 B, and data not shown).
These findings suggest that Notch activity commits lym-
phoid precursors to the T lineage; however, pre-TCR sig-
nals are required for the proliferative burst that accompa-
nies thymocyte differentiation.
Pre-TCR Signals Provide a Permissive Environment for Notch
Induction of T Cell Leukemia. Although the Notch1-
induced BM DP population in wild-type mice is initially
composed of a oligoclonal population of small resting lym-
phocytes, additional events (presumably the acquisition of
other genetic lesions) ensue that result in a lethal mono-
clonal leukemia. We compared the ability of ICN1 to in-
duce T cell leukemia when expressed in Rag-2 /  HSCs,
in which T lineage commitment but not DP development
is intact, with Rag-2 /     TCR  DO11.10 HSCs, in
which both T lineage commitment and DP development
are unimpaired (Table I). Recipients of ICN1 transduced
HSCs from Rag-2 /  mice and control MigR1 transduced
HSCs from wild-type mice remained alive for  1 yr after
transfer without developing any features of leukemia (Fig.
4 A). In sharp contrast, every mouse receiving ICN1 trans-
duced HSCs from wild-type or Rag-2 /  mice expressing
the DO11.10 TCR  transgene developed T cell leukemia
between 9 and 11 wk after BMT (Fig. 4 A). The T cell
leukemias were similar in latency and phenotype to those
described previously (16, 25), being composed of cycling
cells resembling either the immature single positive (ISP) or
DP stages of T cell development (not shown). Southern
blotting showed that all tumors contained proviral DNA of
the expected size and were donor derived, as judged by the
presence of the TCR  transgene in each sample (data not
shown). Recipients of ICN1-transduced progenitors from
both Rag-2 /  and Rag-2 /    TCR  progenitors ex-
pressed readily detectable levels of Notch1 protein as as-
sessed by Western blot analysis (Fig. 4 B). ICN1 protein
expression in the Rag-2 /  mice was limited to the BM;
whereas, ICN1 expression in the Rag-2 /    TCR  mice
was found in all organs infiltrated by tumor cells (Fig. 4 B,
and not shown). Thus, ICN1-mediated transformation of
T cell progenitors required expression of a TCR  chain
and development of CD4 CD8  T cells. More broadly,
ICN1 expression in Rag2 /  HSCs did not induce malig-
nancy in other hematopoietic lineages, suggesting that
Notch1-mediated oncogenesis is sharply restricted to the
context of CD4 CD8  T cell progenitors.
Discussion
Our findings reveal two important facets regarding the
induction of T cell development (10) and T cell leukemia
(16, 25) by Notch1 signaling. First, we show that Notch1
activity is sufficient to drive commitment of HSCs to early
T cell progenitor subsets; however, an intact pre-TCR sig-
naling pathway is required to both expand this population
and induce differentiation into DP T cells. Thus, Notch1
signaling induces an extrathymic (but otherwise normal)
Figure 4. Notch1 induction of T cell leukemia requires a functional
TCR  chain. Progenitor cells from wild-type, Rag-2 / , and Rag-2 /   
TCR  (DO11.10) donors were transduced with MigR1 or MigR1-
ICN1 before transfer to irradiated adoptive hosts. (A) Leukemia onset in
mice reconstituted with retrovirally transduced BM cells. Leukemia onset
is defined as the time after BMT when CD4 CD8  DP GFP  T cells ap-
pear in the peripheral circulation, and/or the WBC exceeds 50   106
cells/ml. Mice typically survived for  1–2 mo after the onset of leuke-
mia, during which time the fraction and number of DP GFP  cells con-
tinued to increase (not shown). None of the mice reconstituted with the
Rag-2 /  receiving Mig ICN or any of the mice receiving the empty
MigR1 virus developed circulating DP GFP  cells or any evidence of
neoplasia. Each dot on the Mig ICN Rag-2 /    TCR  (DO11.10)
curve represents the analysis of two mice. Although this figure shows leu-
kemia-free survival to 100 d, these mice remained leukemia-free for the
duration of this study (see Table I) (B). Western blot analysis of Notch1
expression in BM cells of recipients of ICN1-transduced progenitors from
Rag-2 /  and Rag-2 /    TCR  (DO11.10) donors.104 Notch1-mediated T Cell Commitment and Malignant Transformation
T cell developmental program. Second, we show that
Notch1-induced T cell leukemia requires pre-TCR signal-
ing, as recipients of ICN1-transduced BM from SLP-76 / 
or Rag-2 /  (but not Rag-2 /    TCR ) mice failed to
develop malignancies and remained healthy for longer than
1 yr after BMT. In the presence of pre-TCR signaling,
however, all mice developed fatal T cell leukemias. To-
gether, these data suggest that among hematopoietic lin-
eages, Notch1-transforming activity is limited to immature
T cells with productive TCR  rearrangements.
These studies clearly show that Notch1-induced T cell
commitment is separate from the TCR -induced prolifer-
ative burst associated with the development of early DP
thymocytes, and are consistent with an instructive role for
Notch1 signaling in T cell commitment. Supporting this
model, conditional Notch1 /  mice show that Notch1 is
required for the earliest stage of T lineage commitment (9,
26). Of note, another gene required for early T cell devel-
opment, HES1, is a known target of activated Notch1 (27).
Although Notch appears to play an instructive role in early
T cell development, it is difficult to rule out influences of
Notch signaling on cell survival and/or proliferation. In
fact, Notch signaling is associated with transcriptional up-
regulation of several genes among DN thymocytes includ-
ing pre-T , CD25, Meltrin, Ifi-204, Hes1, and Deltex
(28). In addition, Notch upregulates Bcl2 expression in
some T cell hybridoma lines (29) and suppresses E2A activ-
ity (10, 30), and both genes function at early stages of T
cell development. Thus, because Notch1 appears to alter
the expression of a wide array of genes with unrelated
functions, one possibility is that Notch signaling integrates
multiple aspects of early T cell differentiation including lin-
eage commitment, proliferation, and survival.
Notch signaling was unable to rescue DP T cell develop-
ment in Rag-2– or SLP-76–deficient donors, both of
which exhibit a complete block in pre-TCR signaling and
a developmental arrest before the DP stage. These findings
contrast with reports demonstrating that constitutive lck or
ras signals complement defects in pre-TCR signaling (19–
21). Thus, Notch1 signals do not result in sufficient activa-
tion of these pathways to rescue the Rag-2 /  block. In-
terestingly, it has been reported that Notch might suppress
ras signaling (23, 30). We do not, however, see clear evi-
dence for such an effect in early DP T cell development, as
inhibition of ras signaling would be expected to suppress
DP T cell development (31), yet wild-type ICN1-trans-
duced progenitors give rise to abundant numbers of ex-
trathymic DP T cells. This is consistent with a model in
which Notch signaling promotes T cell commitment from
early progenitors; however, expansion and further differen-
tiation of this pool is dependent on signals from the pre-
TCR that are sufficient to overcome Notch inhibitory ef-
fects on the ras/MAP kinase signaling pathway. The inabil-
ity of Notch1 signals to induce DP development from
Rag-2 /  progenitors also contrasts with studies in which
p53 /    Rag-2 /  mice exhibit significant numbers of
DP thymocytes (32). However, these cells likely result
from the absence of p53-dependent apoptotic mechanisms,
and thus bear no obvious connection with the ability of
Notch1 signals to drive DP T cell development from ear-
lier progenitor populations.
Our results also show that the oncogenic potential of
Notch requires T cell–specific signals for leukemic transfor-
mation. Thus, recipients of ICN1-transduced Rag-2 / 
HSCs remained healthy, whereas, recipients of ICN-trans-
duced Rag-2 /    TCR  cells developed an aggressive T
cell leukemia that was indistinguishable in both latency and
phenotype to recipients of wild-type ICN1-transduced
progenitors. This suggests that the additional genetic events
required for Notch-induced leukemic transformation are
either initiated or revealed by TCR -induced pre-TCR
expression, rather than RAG-induced illegitimate recom-
bination. A recent study suggests that ras signaling cooper-
ates with Notch4 to transform murine breast cancer cell
lines (33). It is possible that similar pathways activated by
TCR signaling synergize with Notch to promote both T
cell expansion and leukemic transformation.
Although unlikely to be oncogenic by itself, TCR  sig-
naling provides a permissive environment for ICN1-medi-
ated T cell transformation. This contrasts with other mouse
models for T cell malignancy. For instance, p53 /  mice
develop thymic lymphomas with no dependence on active
V D J  recombination (34). Likewise, initial studies on
thymoma incidence in ATM /  mice suggested that tumor
formation in these mice resulted from the inability to repair
double-stranded breaks resulting from V(D)J rearrange-
ments, as thymoma incidence was significantly reduced in
both Rag-2 /  and Rag-2 /    TCR  mice (35). How-
ever, a more recent report indicates that thymomas also de-
velop in ATM /  mice (albeit with longer latencies) via a
Rag-independent mechanism (36). Thus, the dependence
of Notch1-induced leukemia on pre-TCR signaling and
DP T cell development is unique among current models of
T lymphoblastic malignancy.
Although the mechanisms underlying Notch1-mediated
T cell leukemia remain to be elucidated, it is likely that ad-
ditional Rag-1/2–independent genetic abnormalities out-
side the TCR  locus play a significant role in this process.
It was recently noted that chromosome abnormalities in
thymoma prone ATM /  mice are detectable in premalig-
Table I. Onset of Notch1-induced Leukemia in Recipients of 
Rag-2 /  versus Rag-2 /    TCR  Progenitors 
Donor cells Construct
No. of
BM
recipients
No.
devoloping
leukemia
Mean
onset
(d)
Range of
onset
(d)
Rag2 /  MigR1 6 0 (455)  
ICN 12 0 (455)  
Rag2 /    TCR  MigR1 5 0 (243)  
ICN 6 6 65 59–76
The number in parentheses in the “mean onset” column indicate the
length of time that these mice were followed. None of these mice
developed a malignancy.105 Allman et al. Brief Definitive Report
nant T cells (36). It would be of interest to determine
whether similar aberrations can be detected within ICN1-
induced resting DP or even CD44 CD25  or CD44 
CD25  BM populations, or if recurrent chromosomal aber-
rations can be identified in fatal Notch1-induced leukemias.
Regardless, our studies emphasize that developing T cells
are uniquely sensitive to Notch-induced transformation.
Our in vivo model should be useful to dissect both the
Notch-induced signals required for T cell commitment and
understanding the TCR -induced secondary genetic
events that cause malignant transformation, and raise the
possibility that interfering with TCR signaling may be of
therapeutic benefit in treating some types of leukemia.
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